tiprankstipranks
Trending News
More News >
Cabaletta Bio (CABA)
NASDAQ:CABA
US Market

Cabaletta Bio (CABA) Income Statement

Compare
1,397 Followers

Cabaletta Bio Income Statement

Last quarter (Q3 2025), Cabaletta Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cabaletta Bio's net income was $-44.87M. See Cabaletta Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -4.81M$ -1.43M$ -3.68M$ -733.00K$ -354.00K
Operating Expenses
$ 120.33M$ 73.23M$ 50.45M$ 45.58M$ 33.48M
Depreciation and Amortization
$ 4.81M$ 1.43M$ 3.68M$ 733.00K$ 354.00K
EBITDA
$ -110.30M$ -66.25M$ -49.29M$ -45.56M$ -32.98M
Operating Income
$ -125.14M$ -74.66M$ -54.14M$ -46.31M$ -33.83M
Other Income/Expenses
$ 9.28M$ 6.99M$ 1.16M$ 24.00K$ 494.00K
Pretax Income
$ -115.86M$ -67.67M$ -52.98M$ -46.29M$ -33.34M
Net Income
$ -115.86M$ -67.67M$ -52.98M$ -46.29M$ -33.34M
Per Share Metrics
Basic EPS
$ -2.34$ -1.65$ -1.81$ -1.80$ -1.44
Diluted EPS
$ -2.34$ -1.65$ -1.81$ -1.80$ -1.44
Weighted Average Shares Outstanding
49.52M 40.95M 29.34M 25.74M 23.14M
Weighted Average Shares Outstanding (Diluted)
49.47M 40.95M 29.34M 25.74M 23.14M
Currency in USD

Cabaletta Bio Earnings and Revenue History